In this podcast, Daphne Koller, founder and CEO of insitro, discusses the intersection of AI and life sciences, particularly in the field of drug discovery. She highlights the unique challenges and opportunities in applying AI to life sciences, emphasizing the ability to measure biology at scale and deploy machine learning in meaningful ways.
Koller explains how insitro utilizes AI to engineer drug discovery, including the development of a Language Model for cells (LLM) that enables the analysis of large cellular datasets.
The podcast covers topics such as the importance of bridging the technological and cultural gap between building with atoms and building with bits, the role of AI in generating and interpreting biological data, and the potential impact of AI on various aspects of biology beyond drug discovery, including agriculture and environmental applications.
In this podcast Koller also shares insights into company building, emphasizing the importance of creating a culture that fosters collaboration between experts in machine learning and life sciences. Overall, the discussion explores the transformative potential of the convergence between AI and life sciences, envisioning a future era of digital biology.